Funding Opportunity RFA-HD-20-008 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to encourage the use of a phased research approach to generate information needed to develop interventions to reduce long-term effects of in utero exposure to antiretroviral therapy (ART) and/or HIV on health outcomes. This FOA will support two-phased research applications to (1) demonstrate the capacity to enroll sufficient numbers of HIV-exposed uninfected (HEU) infants, children, adolescents, and/or young adults in the United States and/or international settings with high HIV burden, and then, to (2) utilize the established cohort with innovative epidemiological approaches to conduct research.

Notice NOT-MH-19-051 from the NIH Guide for Grants and Contracts

Funding Opportunity PAR-19-380 from the NIH Guide for Grants and Contracts. The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The overarching goal of this NHGRI R25 program is to support educational activities that The overarching goal of this NHGRI R25 program is to support educational activities that enhance the diversity of the biomedical, behavioral and clinical research workforce in genomics. This funding opportunity announcement seeks to expose underrepresented students at the undergraduate, post-baccalaureate and graduate levels to the foundational sciences relevant to genomics to enable them to pursue careers that span all areas of interest to NHGRI - genome sciences, genomic medicine and genomics and society. For the purposes of this FOA, the term genomics encompasses issues and activities in these three areas of genomic research.

Funding Opportunity PAR-19-381 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement is to encourage grant applications that address the influence of patient activation on self-management of chronic conditions.

Funding Opportunity PAR-19-382 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement is to encourage grant applications that address the influence of patient activation on self-management of chronic conditions.

Funding Opportunity RFA-ES-20-003 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to accelerate multidisciplinary research projects studying the effects of environmental chemicals on maternal physiology, and endocrine and metabolic functions during and shortly after pregnancy, as well as potential long-term maternal health effects caused by environmental exposures.

Funding Opportunity RFA-DA-20-026 from the NIH Guide for Grants and Contracts. The scientific objective of this Funding Opportunity Announcement is to encourage research to delineate the role of inflammasomes in the neuropathology produced by acute or chronic drug exposure and HIV infection. Understanding the involvement of inflammasomes in virus and drug-induced immune activation may help identify molecular markers and CNS immune cells associated with HIV-1 infection or disease progression among substance abuse populations, as well as identify novel therapies to target inflammasome activation or suppression to treat neuroinflammation and immune dysregulation aroused in these processes.

Notice NOT-OD-19-146 from the NIH Guide for Grants and Contracts

Funding Opportunity PAR-19-383 from the NIH Guide for Grants and Contracts. The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The over-arching goal of this NIGMS R25 program is to support educational activities that complement and/or enhance the training of a diverse workforce to meet the nations biomedical research needs. To accomplish the stated over-arching goal, this FOA will support creative educational activities with a primary focus on skills development, mentoring, and outreach to equip a diverse cohort of participants with the technical, operational, and professional skills required for careers in the biomedical research workforce. Funded programs are expected to have robust evaluation, dissemination, and sustainability plans.

Funding Opportunity RFA-CA-19-054 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA) is a continuation of Cancer Intervention and Surveillance Modeling Network (CISNET - https://cisnet.cancer.gov) program. This FOA invites applications for collaborative research projects using simulation and other modeling techniques for specific cancer types (see below). The proposed research is expected to generate sophisticated, evidence-based decision tools that could inform international/national/regional/local decisions on the most efficient utilization of existing and emerging technologies and strategies for the control of cancer

Funding Opportunity PAR-19-378 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) does not allow applicants to propose to lead an independent clinical trial, but does allow applicants to propose research experience in a clinical trial led by a sponsor or co-sponsor.

Funding Opportunity PAR-19-379 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) does not allow applicants to propose to lead an independent clinical trial, but does allow applicants to propose research experience in a clinical trial led by a sponsor or co-sponsor.

Notice NOT-MD-20-004 from the NIH Guide for Grants and Contracts

Notice NOT-HD-19-027 from the NIH Guide for Grants and Contracts

Notice NOT-NS-20-006 from the NIH Guide for Grants and Contracts

Notice NOT-OD-19-145 from the NIH Guide for Grants and Contracts

Notice NOT-NS-20-009 from the NIH Guide for Grants and Contracts

Notice NOT-DA-19-075 from the NIH Guide for Grants and Contracts

Notice NOT-DA-19-074 from the NIH Guide for Grants and Contracts

Notice NOT-AG-19-043 from the NIH Guide for Grants and Contracts